Optical coherence tomography in coronary atherosclerosis assessment and intervention

Makoto Araki(Massachusetts General Hospital), Seung‐Jung Park(Korea Advanced Institute of Science and Technology), Harold L. Dauerman(University of Vermont), Shiro Uemura(Kawasaki Medical School), Jung‐Sun Kim(Yonsei University), Carlo Di Mario(Azienda Ospedaliero-Universitaria Careggi), Tom Johnson(University Hospitals Bristol NHS Foundation Trust), Giulio Guagliumi(Ospedale Papa Giovanni XXIII), Adnan Kastrati(Bavarian Research Alliance), Michael Joner(Deutsches Herzzentrum München), Niels Ramsing Holm(Aarhus University Hospital), Fernándo Alfonso(Hospital Universitario de La Princesa), William Wijns(Ollscoil na Gaillimhe – University of Galway), Tom Adriaenssens, Holger Nef(Justus-Liebig-Universität Gießen), Gilles Rioufol(Université Claude Bernard Lyon 1), Nicolas Amabile(Institute Mutualiste Montsouris), Géraud Souteyrand(Centre Hospitalier Universitaire de Clermont-Ferrand), Nicolas Piriou(Centre Hospitalier Universitaire de Besançon), Édouard Gerbaud(Université de Bordeaux), Maksymilian P. Opolski(Institute of Cardiology), Nieves Gonzalo(Hospital Clínico San Carlos), Guillermo J. Tearney(Massachusetts General Hospital), Brett E. Bouma(Massachusetts General Hospital), Aaron D. Aguirre(Massachusetts General Hospital), Gary S. Mintz(Cardiovascular Research Foundation), Gregg W. Stone(Icahn School of Medicine at Mount Sinai), Christos V. Bourantas(Queen Mary University of London), Lorenz Räber(University of Bern), Sebastiano Gili(Centro Cardiologico Monzino), Kyoichi Mizuno(Mitsukoshi Health and Welfare Foundation), Shigeki Kimura(Yokohama Minami Kyosai Hospital), Toshiro Shinke(Showa University Hospital), Myeong‐Ki Hong(Yonsei University), Yangsoo Jang(Yonsei University), Jin Man Cho(Kyung Hee University), Bryan P. Yan(Chinese University of Hong Kong), Italo Porto(University of Genoa), Giampaolo Niccoli(University of Parma), Rocco Antonio Montone(Università Cattolica del Sacro Cuore), Vikas Thondapu(Massachusetts General Hospital), Michail I. Papafaklis(University Hospital of Ioannina), Lampros K. Michalis(University Hospital of Ioannina), Harmony R. Reynolds(New York University), Jacqueline Saw(University of British Columbia), Peter Libby(Brigham and Women's Hospital), Giora Weisz(NewYork–Presbyterian Hospital), Mario Iannaccone(Ospedale San Giovanni Bosco), Tommaso Gori, Konstantinos Tοutouzas(National and Kapodistrian University of Athens), Taishi Yonetsu(Tokyo Medical and Dental University), Yoshiyasu Minami(Kitasato University), Masamichi Takano(Chiba Hokusou Hospital), O. Raffel(Prince Charles Hospital), Osamu Kurihara(Chiba Hokusou Hospital), Tsunenari Soeda(Nara Medical University), Tomoyo Sugiyama(Tsuchiura Kyodo General Hospital), Hyung Oh Kim(Kyung Hee University), Tetsumin Lee(Musashino Red Cross Hospital), Takumi Higuma(St. Marianna University School of Medicine), Akihiro Nakajima(Massachusetts General Hospital), Erika Yamamoto(Kyoto University), Krzysztof Bryniarski(Jagiellonian University), Luca Di Vito, Rocco Vergallo(Università Cattolica del Sacro Cuore), Francesco Fracassi(Università Cattolica del Sacro Cuore), Michele Russo(Università Cattolica del Sacro Cuore), Lena Marie Seegers(Massachusetts General Hospital), Iris McNulty(Massachusetts General Hospital), Sang Joon Park(Korea Advanced Institute of Science and Technology), Marc D. Feldman(The University of Texas at San Antonio Health Science Center), Javier Escaned(Hospital Clínico San Carlos), Francesco Prati(Saint Camillus International University of Health and Medical Sciences), Eloisa Arbustini(Policlinico San Matteo Fondazione), Fausto J. Pinto(University of Lisbon), Ron Waksman(MedStar Washington Hospital Center), Héctor M. García‐García(MedStar Washington Hospital Center), Akiko Maehara(Cardiovascular Research Foundation), Ziad A. Ali(Cardiovascular Research Foundation), Aloke V. Finn(CVPath Institute), Renu Virmani(CVPath Institute), Annapoorna Kini(Mount Sinai Hospital), Joost Daemen(Erasmus University Rotterdam), Teruyoshi Kume(Kawasaki Medical School), Kiyoshi Hibi(Yokohama City University Medical Center), Atsushi Tanaka(Wakayama Medical University), Takashi Akasaka(Wakayama Medical University), Takashi Kubo(Wakayama Medical University), Satoshi Yasuda(Tohoku University), Kevin Croce(Brigham and Women's Hospital), Juan F. Granada(Cardiovascular Research Foundation), Amir Lerman(Mayo Clinic in Arizona), Abhiram Prasad(Mayo Clinic in Arizona), Evelyn Regar(University Hospital of Zurich), Yoshihiko Saito(Gifu University), Mullasari Ajit Sankardas(Madras Medical Mission), Vijayakumar Subban(Madras Medical Mission), Neil J. Weissman(MedStar Health), Yundai Chen(Chinese PLA General Hospital), Bo Yu(Harbin Medical University), Stephen J. Nicholls(Monash University), Peter Barlis(The University of Melbourne), Nick E.J. West(Papworth Hospital), Armin Arbab‐Zadeh(Johns Hopkins University), Jong Chul Ye(Korea Advanced Institute of Science and Technology), Jouke Dijkstra(Leiden University Medical Center), Hang Lee(Massachusetts General Hospital), Jagat Narula(Icahn School of Medicine at Mount Sinai), Filippo Crea(Università Cattolica del Sacro Cuore), Sunao Nakamura(New Tokyo Hospital), Tsunekazu Kakuta(Tsuchiura Kyodo General Hospital), James G. Fujimoto(Massachusetts Institute of Technology), Valentı́n Fuster(Icahn School of Medicine at Mount Sinai), Ik‐Kyung Jang(Kyung Hee University)
Nature Reviews Cardiology
April 21, 2022
Cited by 392Open Access
Full Text

Abstract

Since optical coherence tomography (OCT) was first performed in humans two decades ago, this imaging modality has been widely adopted in research on coronary atherosclerosis and adopted clinically for the optimization of percutaneous coronary intervention. In the past 10 years, substantial advances have been made in the understanding of in vivo vascular biology using OCT. Identification by OCT of culprit plaque pathology could potentially lead to a major shift in the management of patients with acute coronary syndromes. Detection by OCT of healed coronary plaque has been important in our understanding of the mechanisms involved in plaque destabilization and healing with the rapid progression of atherosclerosis. Accurate detection by OCT of sequelae from percutaneous coronary interventions that might be missed by angiography could improve clinical outcomes. In addition, OCT has become an essential diagnostic modality for myocardial infarction with non-obstructive coronary arteries. Insight into neoatherosclerosis from OCT could improve our understanding of the mechanisms of very late stent thrombosis. The appropriate use of OCT depends on accurate interpretation and understanding of the clinical significance of OCT findings. In this Review, we summarize the state of the art in cardiac OCT and facilitate the uniform use of this modality in coronary atherosclerosis. Contributions have been made by clinicians and investigators worldwide with extensive experience in OCT, with the aim that this document will serve as a standard reference for future research and clinical application.


Related Papers

No related papers found

Powered by citation graph analysis